EPIMMUNE INC.
Patent Owner
Stats
- 17 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 17, 2017 most recent publication
Details
- 17 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 800 Total Citation Count
- May 04, 1993 Earliest Filing
- 22 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9511134 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositionsMay 18, 07Dec 06, 16[A61K, C07K]
7611713 Inducing cellular immune responses to hepatitis B virus using peptide compositionsSep 04, 03Nov 03, 09[A61K]
7572882 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositionsDec 11, 00Aug 11, 09[A61K]
7462354 Method and system for optimizing minigenes and peptides encoded therebyJun 27, 01Dec 09, 08[A61K]
7026443 Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositionsAug 15, 00Apr 11, 06[C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0193,316 Inducing Cellular Immune Responses to Plasmodium Falciparum Using Peptide and Nucleic Acid CompositionsAbandonedDec 28, 15Jul 07, 16[A61K, C07K]
2013/0017,253 Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid CompositionsAbandonedSep 14, 12Jan 17, 13[A61K, C12N, A61P, C07K]
2012/0015,401 PLASMODIUM FALCIPARUM ANTIGENS AND METHODS OF USEAbandonedJul 25, 11Jan 19, 12[C07H, C12P, C12N]
2010/0049,491 Method and System for Optimizing Minigenes and Peptides Encoded TherebyAbandonedDec 08, 08Feb 25, 10[G06F]
2009/0214,632 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositionsAbandonedNov 14, 08Aug 27, 09[A61K, C07H, C12N, C07K]
7364741 Peptides of human Papilloma virus for use in human T cell response inducing compositionsExpiredMay 04, 93Apr 29, 08[A61K]
2007/0184,519 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their productionAbandonedApr 02, 04Aug 09, 07[A61K, C07H, C12P, C07K]
7202351 Alteration of immune response using pan DR-binding peptidesExpiredNov 08, 00Apr 10, 07[C07H]
2007/0054,262 Methods of identifying optimal variants of peptide epitopesAbandonedMar 29, 04Mar 08, 07[C12Q, G01N]
2005/0049,197 Induction of immune response against desired determinantsAbandonedOct 07, 04Mar 03, 05[A61K]
2004/0146,519 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositionsAbandonedOct 22, 02Jul 29, 04[A61K]
2004/0053,822 Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositionsAbandonedOct 21, 02Mar 18, 04[A61K, C07K]
2004/0048,790 Inducing cellular immune responses to p53 using peptide and nucleic acid compositionsAbandonedNov 18, 02Mar 11, 04[A61K, C07K]
2004/0037,843 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositionsAbandonedJan 14, 03Feb 26, 04[A61K, C07K]
2003/0224,036 Hla class I a2 tumor associated antigen peptides and vaccine compositionsAbandonedOct 15, 02Dec 04, 03[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.